| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.092 | 0.009 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.01 |